SANJUANA GONZALEZ: Open Payments
NPI 1609576529 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 39 payments from 13 companies in 2025. Trend: 2023 $347 · 2024 $592 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $291 |
| Axsome Therapeutics, Inc. | 3 | $129 |
| Phathom Pharmaceuticals, Inc. | 1 | $105 |
| ABBVIE INC. | 5 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Novo Nordisk Inc | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: CAPLYTA, Auvelity, VOQUEZNA, VRAYLAR, REXULTI, TRINTELLIX, Ozempic, FANAPT.
Industry payments across MS — which companies pay providers there.
